John Engelhardt
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 14
- CAR-T cell therapy research 2
- Immunology 14
- Immunotherapy and Immune Responses 7
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 4
- Immune cells in cancer 2
- Co-authors
- Alan J. Korman (8 shared papers)Michael Quigley (3 shared papers)Tseng-hui Timothy Chen (1 shared paper)M. S. Srinivasan (1 shared paper)M. J. Selby (1 shared paper)Karla A. Henning (2 shared papers)Mark Selby (7 shared papers)Rony Dahan (1 shared paper)
- Journals
- Cancer Research (7 papers)Cancer Cell (2 papers)Journal of Clinical Oncology (2 papers)PLoS ONE (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
John Engelhardt
19 papers receiving 1.7k citations
John Engelhardt's Hit Papers
Peers
Comparison fields: 5 of 73
- Immunology 1.1k
- Oncology 1.2k
- Radiology, Nuclear Medicine and Imaging 201
- Genetics 58
- Cancer Research 78
Countries citing papers authored by John Engelhardt
This map shows the geographic impact of John Engelhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Engelhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Engelhardt more than expected).
Fields of papers citing papers by John Engelhardt
This network shows the impact of papers produced by John Engelhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Engelhardt. The network helps show where John Engelhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside John Engelhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells Hit paper breakdown → | 2013 | 692 |
| 2 | 2015 | 296 | |
| 3 | 2012 | 275 | |
| 4 | 2016 | 181 | |
| 5 | 2006 | 106 | |
| 6 | 2020 | 71 | |
| 7 | 2013 | 60 | |
| 8 | 2022 | 20 | |
| 9 | 2023 | 19 | |
| 10 | 2019 | 14 | |
| 11 | 2017 | 11 | |
| 12 | 2018 | 10 | |
| 13 | 2020 | 6 | |
| 14 | 2021 | 5 | |
| 15 | 2020 | 4 | |
| 16 | 1995 | 4 | |
| 17 | 2013 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 0 |
About John Engelhardt
John Engelhardt is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 20 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (4 papers), Glycosylation and Glycoproteins Research (3 papers), Immune cells in cancer (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (1.2k citations), Radiology, Nuclear Medicine and Imaging (201 citations), Genetics (58 citations) and Cancer Research (78 citations). John Engelhardt has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Alan J. Korman, Michael Quigley, Tseng-hui Timothy Chen, M. S. Srinivasan, M. J. Selby, Karla A. Henning, Mark Selby, Rony Dahan, Emanuela Sega and Jeffrey V. Ravetch. Their work appears in journals such as Cancer Research, Cancer Cell, Journal of Clinical Oncology, PLoS ONE and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.